Characteristics of Parkinson’s disease and associated healthcare resource utilization trends in a US all-payer health administrative claims database
Objective: To describe sociodemographic characteristics and healthcare resource utilization (HRU) among Parkinson’s disease (PD) patients across US health insurance plans. Background: PD affects nearly 1…Gender Differences in Physical Activity in Parkinson’s Disease
Objective: Examine gender differences in physical activity in different stages of Parkinson’s disease (PD). Background: Physical activity has been linked to slower progression and improvement…Depressive Symptomatology and Neuropsychiatric Profile in Patients with Idiopathic Parkinson’s Disease without Dementia (IPDWD). Preliminary Data from a New Scale Specifically for Measuring Depression in Patients with IPDWD.
Objective: : To identify whether depression in patients with IPDWD correlates with different types of behavioral symptoms. Background: Depression is considered a frequent neuropsychiatric pathology…An Analysis of Baseline Measures from a Diverse Parkinson’s Disease Interdisciplinary Clinic
Objective: To analyze differences in baseline characteristics of patients at a new diverse, academic Parkinson’s Disease (PD) interdisciplinary clinic (IDC). Background: The University of Miami…Cross-cultural adaptation to Argentine Spanish and validation of the High Level Mobility Assessment Tool in individuals with Parkinson’s disease
Objective: To translate and adapt the High-Level Mobility Assessment Tool (HiMAT) into Argentine Spanish and evaluate its psychometric properties in individuals with Parkinson's disease (PD).…Developing a Virtual Brick-Building Group for Veterans with Movement Disorders
Objective: To improve quality of life for Veterans with movement disorders by creating a virtual group using building bricks Background: Parkinson’s disease (PD) may cause…“Quality of Life of Caregivers Living with a Movement Disorder. A Comprehensive Approach.”
Objective: Exploring self-perceived health, quality of life, economic factors, and social-work aspect of caregivers of patients living with some type of movement disorder. Background: Caregivers…Quality of Life with 24-hour Subcutaneous Levodopa/Carbidopa Infusion (ND0612): PDQ-39 Results from a Phase 3 Randomized Active-Controlled Study
Objective: Evaluate quality of life (QoL) data from the Phase 3 randomized, active-controlled BouNDless study. Background: Pivotal data from the BouNDless study (NCT04006210) showed that…Gait Digital Outcomes Exploration from Continuous Real-World Recordings in Parkinson’s Disease
Objective: To measure how people with Parkinson's disease (PD) feel, function, and survive, derived from continuous recordings with a wearable ankle inertial device in a real-world…Efficacy of Continuous Subcutaneous Levodopa/Carbidopa Infusion (ND0612) on Motor Signs of PD and Experiences of Daily Living
Objective: Evaluate the effect of investigational ND0612 on motor signs of PD and motor experiences of daily living (m-EDL), as assessed using the MDS-UPDRS. Background:…
- « Previous Page
- 1
- …
- 139
- 140
- 141
- 142
- 143
- …
- 436
- Next Page »